Park Ha Valuation
PHH Stock | 5.93 0.69 13.17% |
At this time, the company appears to be undervalued. Park Ha Biological holds a recent Real Value of 7.51 per share. The prevailing price of the company is 5.93. Our model determines the value of Park Ha Biological from analyzing the company fundamentals such as Profit Margin of 0.21 %, number of shares shorted of 2.78 K, and Shares Outstanding of 26.2 M as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Park Ha's valuation include:
Price Book 130.999 | Enterprise Value | Enterprise Value Ebitda 224.6105 | Price Sales 76.8268 | Trailing PE 284.5 |
Undervalued
Today
Please note that Park Ha's price fluctuation is risky at this time. Calculation of the real value of Park Ha Biological is based on 3 months time horizon. Increasing Park Ha's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Park Ha is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Park Stock. However, Park Ha's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. Historical | Market 5.93 | Real 7.51 | Target 15.0 | Hype 6.11 |
The intrinsic value of Park Ha's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Park Ha's stock price.
Estimating the potential upside or downside of Park Ha Biological helps investors to forecast how Park stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Park Ha more accurately as focusing exclusively on Park Ha's fundamentals will not take into account other important factors: When choosing an evaluation method for Park Ha Biological, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using all methods to arrive at a better estimate.
Park Ha Cash |
|
Park Valuation Trend
Park Ha's real value analysis enables investors to forecast the earnings more efficiently. Using both Park Ha's enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing decisions.
Park Ha Total Value Analysis
Park Ha Biological is at this time forecasted to have company total value of 139 M with market capitalization of 149.08 M, debt of 31.46 K, and cash on hands of 455 M. Please note that company total value may be misleading and is a subject to accounting gimmicks. We encourage investors to carefully check all of the Park Ha fundamentals before making security assessment based on enterprise value of the companyTakeover Price | Market Cap | Debt Obligations | Cash |
139 M | 149.08 M | 31.46 K | 455 M |
Park Ha Investor Information
About 82.0% of the company outstanding shares are owned by corporate insiders. The company had not issued any dividends in recent years. Based on the key measurements obtained from Park Ha's financial statements, Park Ha Biological may be sliding down financialy. It has an above-average chance of going through some form of financial crunch next quarter.Park Ha Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The recent return on assets of Park signifies not a very effective usage of assets in January.Park Ha Ownership Allocation
Park Ha owns a total of 26.2 Million outstanding shares. Park Ha holds majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 81.7 pct. of Park Ha Biological outstanding shares that are owned by insiders implies they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.Park Ha Profitability Analysis
The company reported the last year's revenue of 2.46 M. Total Income to common stockholders was 852.04 K with profit before taxes, overhead, and interest of 1.66 M.About Park Ha Valuation
An absolute valuation paradigm, as applied to Park Stock, attempts to find the value of Park Ha Biological based on its fundamental and basic technical indicators. By analyzing Park Ha's financials, quarterly and monthly indicators, and their related drivers, such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Park Ha's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Park Ha. We calculate exposure to Park Ha's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Park Ha's related companies.Last Reported | Projected for Next Year | ||
Gross Profit | 1.9 M | 1.8 M | |
Pretax Profit Margin | (0.54) | (0.51) | |
Operating Profit Margin | (0.58) | (0.56) | |
Net Loss | (0.38) | (0.36) | |
Gross Profit Margin | 0.79 | 0.61 |
Park Ha Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
Common Stock Shares Outstanding | 26.2 M | |
Quarterly Earnings Growth Y O Y | -0.902 |
Park Ha Current Valuation Indicators
Valuation refers to the process of determining the present value of Park Ha Biological and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Park we look at many different elements of the entity such as Park's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Park Ha, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Park Ha's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Park Ha's worth.Complementary Tools for Park Stock analysis
When running Park Ha's price analysis, check to measure Park Ha's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Park Ha is operating at the current time. Most of Park Ha's value examination focuses on studying past and present price action to predict the probability of Park Ha's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Park Ha's price. Additionally, you may evaluate how the addition of Park Ha to your portfolios can decrease your overall portfolio volatility.
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Stocks Directory Find actively traded stocks across global markets | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |